In 2014, Caremark was accused of manipulating how drug costs were reported, prompting Aetna and SilverScript to submit false ...

Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the federal False Claims Act.

A federal judge has ordered CVS Caremark to pay almost $290 million in damages and penalties after a whistleblower proved the ...

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

CVS Caremark, CVS Health’s (NYSE:CVS) pharmacy benefit manager, has been ordered by a federal judge to pay $289.9M in damages ...

A federal judge has ordered CVS Health's PBM Caremark to pay nearly $290 million after a whistleblower accused the business of overcharging Medicare on prescription drugs more than a decade ago.

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

CVS Health, which operates the largest U.S. pharmacy benefit manager, will not add Gilead Sciences’ new HIV prevention drug ...

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.

In April it closed its $1.25 billion acquisition of Medicare Part D company Universal American, a move that added 1.9 Part D members and more than doubled the company's Part D membership to 3.1 ...

CVS Caremark is striving to acquire a leading position in the Medicare Prescription Drug Plan business in the U.S. It aggressively grew its Pharmacy Benefits Management business in 2011, winning ...